Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† (2020) Pavel ME, Öberg K, Falconi M, Krenning EP, Sundin A, Perren A, Berruti A Journal article Kniffelige Fälle – Wann bringt die Labordiagnostik eine Lösung? (2020) Mettang T, Kremer A Journal article, Review article Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options (2020) Merola E, Prasad V, Pascher A, Pape UF, Arsenic R, Denecke T, Fehrenbach U, et al. Journal article Inherited CDH1 pathogenic variant: is there a place for surveillance of esophageal gastric inlet patch? (2020) Leclercq P, Jadot V, Bours V, Oliveira C, Neumann H, Bisschops R Journal article Covid-19 and immunomodulation in IBD (2020) Neurath M Journal article, Review article COVID-19: risk for cytokine targeting in chronic inflammatory diseases? (2020) Schett G, Sticherling M, Neurath M Journal article The first real-life multicentre prospective validation study of the electronic chromoendoscopy score (Paddington International Virtual ChromoendoScopy ScOre) and its outcome in ulcerative colitis (2020) Iacucci M, Smith SC, Bazarova A, Shivaji UN, Bhandari P, Cannatelli R, Daperno M, et al. Conference contribution Effectiveness of vedolizumab therapy in a real-world setting in Germany: First results of the VEDOibd study comparing vedolizumab to the use of other biologics (2020) Bokemeyer B, Plachta-Danielzik S, Sobotzki C, Mohl W, Hoffstadt M, Krause T, Atreya R, et al. Conference contribution An IFN-STAT1-MLKL axis drives programmed necrosis of Paneth cells in Crohn's ileitis (2020) Hartmann L, Siegmund B, Weidinger C, Becker C, Neurath M, Günther C Conference contribution Efficacy, safety, and pharmacokinetics after switching from infliximab originator to biosimilar SB2 in inflammatory bowel disease patients: A long-term observational, prospective cohort study (2020) Fischer S, Mesfin SE, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Conference contribution